Tepezza hearing loss litigation — safety… | DrugsMonitor.com

Clinical summary and reported injury patterns for Tepezza hearing loss litigation. Links to FDA recalls and litigation overview. Not medical advice.

teprotumumab, thyroid eye disease, tinnitus, sensorineural hearing loss

Clinical context

Ang Teprotumumab para sa thyroid eye disease ay sinasabing nagdudulot ng permanenteng pagkawala ng pandinig at tinnitus sa ilang pasyente.

Litigation context

MDL No. 3079 sa Northern District ng Illinois; patuloy na pagtuklas.